The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation (2019)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1186/s12933-019-0864-7
- Subjects: DOENÇAS CARDIOVASCULARES; ARTERIOSCLEROSE; DISLIPIDEMIAS; LIPÍDEOS; LIPOPROTEÍNAS HDL; DIABETES MELLITUS NÃO INSULINO-DEPENDENTE; PEROXISSOMOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Cardiovascular diabetology
- ISSN: 1475-2840
- Volume/Número/Paginação/Ano: v. 18, article ID 71, 20p, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FRUCHART, Jean-Charles et al. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. Cardiovascular diabetology, v. 18, 2019Tradução . . Disponível em: https://doi.org/10.1186/s12933-019-0864-7. Acesso em: 24 jan. 2026. -
APA
Fruchart, J. -C., Santos Filho, R. D. dos, Aguilar-salinas, C., Aikawa, M., Rasadi, K. A., Amarenco, P., et al. (2019). The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. Cardiovascular diabetology, 18. doi:10.1186/s12933-019-0864-7 -
NLM
Fruchart J-C, Santos Filho RD dos, Aguilar-salinas C, Aikawa M, Rasadi KA, Amarenco P, Barter PJ, Ceska R, Corsini A, Despres J-P. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation [Internet]. Cardiovascular diabetology. 2019 ; 18[citado 2026 jan. 24 ] Available from: https://doi.org/10.1186/s12933-019-0864-7 -
Vancouver
Fruchart J-C, Santos Filho RD dos, Aguilar-salinas C, Aikawa M, Rasadi KA, Amarenco P, Barter PJ, Ceska R, Corsini A, Despres J-P. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation [Internet]. Cardiovascular diabetology. 2019 ; 18[citado 2026 jan. 24 ] Available from: https://doi.org/10.1186/s12933-019-0864-7 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
Informações sobre o DOI: 10.1186/s12933-019-0864-7 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
